RLAY
Relay Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.36
-0.19 ▼ -1.80%
🌙 3월 13일 7:32 PM ET (한국 3/14 08:32)
$10.41
+0.05 ▲ +0.48%
| Index | RUT | P/E | - | EPS (ttm) | -1.61 | Insider Own | 26.42% | Shs Outstand | 0.17B | Perf Week | 4.75% |
| Market Cap | 1.85B | Forward P/E | - | EPS next Y | 3.78% | Insider Trans | -0.56% | Shs Float | 0.13B | Perf Month | 13.22% |
| Enterprise Value | 1.33B | PEG | - | EPS next Q | -0.36 | Inst Own | 74.23% | Short Float | 14.78% | Perf Quarter | 36.5% |
| Income | -0.28B | P/S | 120.55 | EPS this Y | 4.58% | Inst Trans | 3.49% | Short Ratio | 7.85 | Perf Half Y | 151.46% |
| Sales | 0.02B | P/B | 3.18 | EPS next 5Y | 4.17% | ROA | -37.05% | Short Interest | 19.44M | Perf YTD | 22.46% |
| Book/sh | 3.26 | P/C | 3.34 | EPS past 3/5Y | 14.61% 8.85% | ROE | -41.12% | 52W High | -9.32% ($11.43) | Perf Year | 203.81% |
| Cash/sh | 3.1 | P/FCF | - | Sales past 3/5Y | 123.2% -28.58% | ROIC | -46.41% | 52W Low | 483.66% ($1.77) | Perf 3Y | -35.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 32.76% | Gross Margin | 76.84% | Volatility(W/M) | 7.52% 7.79% | Perf 5Y | -73.63% |
| Dividend TTM | - | EV/Sales | 86.56 | Sales Y/Y TTM | 53.45% | Oper. Margin | -1971.46% | ATR (14) | 0.75 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 22.61 | EPS Q/Q | 30.32% | Profit Margin | -1800.46% | RSI (14) | 61.01 | Recom | 1.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 22.61 | Sales Q/Q | - | SMA20 | 7.15% ($9.67) | Beta | 1.58 | Target Price | $16.5 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 2000000 | SMA50 | 18.79% ($8.72) | Rel Volume | 0.66 | Prev Close | $10.55 |
| Employees | 192 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 20.91% 40.96% | SMA200 | 72.19% ($6.02) | Avg Volume(3M) | 2.48M | Price | $10.36 |
| IPO | 2020/7/16 | Option/Short | Yes/Yes | Trades | 13536 | Volume | 1,632,175 | Change | -1.8% |
뉴스 로딩 중...